Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Infant Bacterial Therapeutics AB
AB
Active
Org 5568738586
Katarina Bangata 70, 116 42
Stockholm
Manufacture of pharmaceutical preparations
· NACE 2120
Est. 2011
10-19 employees
Watchlist
Share
Sweden
/
Companies
/
Manufacture of pharmaceutical preparations
/
Infant Bacterial Therapeutics AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
0M
2022
0M
2023
0M
2024
EBITDA
SEK millions
0M
-13M
-26M
-39M
-52M
-72M
2020
-45M
2021
-66M
2022
-135M
2023
-145M
2024
Income statement
SEK thousands
Item
2020
2021
2022
2023
2024
Revenue
312
94
0
0
0
Staff expenses
—
—
—
—
—
EBITDA
−71 918
−44 578
−65 808
−134 617
−145 343
Depreciation & amort.
—
—
—
—
—
EBIT
−71 918
−44 578
−65 808
−134 617
−145 343
Net financials
−89
−413
357
11 549
8 438
Profit before tax
−72 007
−44 991
−65 451
−123 067
−136 905
Tax
−0
−0
−0
−0
−0
Net profit
−72 007
−44 991
−65 451
−123 067
−136 905
Balance sheet
SEK thousands
Item
2020
2021
2022
2023
2024
Total assets
450 318
408 478
349 619
351 334
239 566
Equity
440 154
395 254
331 705
305 154
170 263
Long-term debt
0
0
0
0
0
Short-term debt
10 164
13 224
17 913
46 180
69 303
Total debt
10 164
13 224
17 913
46 180
69 303
Financial ratios
5-year trend
EBITDA margin
-14534300000.0%
This company
15.8%
Market median
-91989240606% vs market
2020
2024
Equity ratio
71.1%
This company
38.2%
Market median
+86% vs market
2020
2024
Return on equity
-80.4%
This company
18.4%
Market median
-537% vs market
2020
2024
Net profit margin
-13690500000.0%
This company
8.1%
Market median
-169018518619% vs market
2020
2024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2020
2024
Debt / equity
0.41×
This company
0.62×
Market median
+34% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
More on Infant Bacterial Therapeutics AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
